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Studies have shown vitamin (Vit) D deficiency and bone disease in 
long-term use of antiepileptics, especially in young individuals. This 
study aimed to determine the relationship between antiepileptic drugs 
and the level of Vit D, calcium (Ca), and phosphorus (P) in children 
with epilepsy at the Shohada Hospital from 2016 to 2017. 
Materials & Methods
In this case-control study, 60 consecutive children with epilepsy at 
the Shohada Hospital from 2016 to 2017 under treatment with anti-
convulsions for more than six months were enrolled as the case group. 
The level of Vit D, Ca, and P was determined in the case group and 
compared with 60 children without seizure as the control group. 
Results
The mean Ca and P were alike across the groups (P > 0.05). The 
mean Vit D3 level was 31.3 and 40 in the case and control groups, 
respectively, with significant difference (P=0.0001). The mean Ca 
and P were alike across the types of drug in the case group (P > 0.05); 
however, the mean Vit D3 level was lower in the case versus control 
group with significant difference (P=0.040). 
Conclusion
Totally, according to the obtained results, it may be concluded that 
treatment with antiepileptic drugs, especially stimulant type, is related 
to the lower Vit D3 level, but not to the Ca and P levels.
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Introduction
Convulsion is a common medical condition 
which results in epilepsy in 0.5-0.8% of cases 
worldwide. Studies showed that medications 
could keep 70% of patients away from epilepsy, 
even with mono-therapy. Since epileptic disorders 
are more common among children, relevant 
medications are also much more frequently used 
in them. Some of antiepileptic drugs such as 
phenytoin, phenobarbital, and carbamazepine are 
strong stimulants for hepatic microsomal enzymes 
(1), resulting in changes in the metabolism of 
exogenous or endogenous substances (2). These 
drugs usually decrease serum level of Ca and 
vitamin (Vit) D toward osteomalacia (3). In 
children, antiepileptics, immobility, multidrug or 
long-term treatments, and inappropriate nutrition 
are known as aggregating factors in this regard 
(4). Although Vit D supplements are prescribed 
for children in their first two years of life, due to 
multiple issues related to nutrition and life style 
in our country, rickets, hypocalcemia, and other 
relevant medical conditions like immune disorders 
are still common in children (5).
Epilepsy has different types including partial, 
generalized, absence, tonic, clonic, tonic - 
clonic, atonic, and myoclonic, but their details 
and causes are not the main focus of the present 
report. Each category of epilepsy has its choice 
medication; however, phenytoin, phenobarbital, 
carbamazepine, sodium valproate, levetiracetam, 
and lamotrigine are the most commonly used 
medications. Previously, dosages of medications 
were determined through trial and error, lasting for 
months or even more. Recently, the optimal dose 
of anti-seizure drugs has been determined based 
on serum level measurements. Previous studies 
through biochemical and radiological assessment 
confirmed side effects of the metabolism of 
Vit D, calcium (Ca), and phosphorus (P), 
resulting in rickets (5-10). Although Yildiz et al. 
(2017) found no correlation between the serum 
level of Vit D and long-term treatment with 
phenobarbital, carbamazepine, sodium valproate, 
and levetiracetam (11), Fong et al. (2014) reported 
22% and 41% Vit D deficiency and insufficiency, 
respectively (12). The rates were even more in 
Lee’s report in 2015, i.e. 79% Vit D deficiency after 
only 1 year of treatment. The reason was probably 
combined therapy or treatments for more than 2 
years, tube feeding, and overweight condition (13).
Considering the common use of antiepileptics in 
childhood, it is worth assessing their effects on 
Vit D, Ca, and P to know the mechanism of these 
effects so that rickets and hypocalcemia could be 
prevented. To this end, the current study attempted 
to measure the named parameters among children 
taking antiepileptics and compare them with others.
Materials & Methods
Through a case-control study, children with 
epilepsy who were prescribed antiepileptic 
medications for at least 6 months were selected. 
The aim was to compare the serum level of Vit 
D3, Ca, and P. Finally, 120 referrals from 2016 to 
2017 participated in the study by census. There 
was no randomization to select the patients. 
Children with medical conditions affecting 
bone metabolism (hepatic, renal, metabolic, or 
endocrine diseases), chronic diseases (cancer, 
diabetes mellitus, GI tract problems), and moving 
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such as Vit D/Ca supplements or corticosteroids 
causing neuromuscular diseases were excluded 
from the study. The participants were divided into 
two groups including case (60 participants) and 
control (60 participants). Cases were epileptic 
children using antiepileptic medications at least 
for 6 months, and controls were selected from 
referrals to general clinics at the Shohada Hospital, 
Tehran, Iran. The groups were matched for age and 
sex before enrollment, and demographics, types of 
epilepsy, duration of treatment and names of drugs 
were recorded from the charts. A single laboratory 
measured the studied items. Vit D deficiency and 
insufficiency were defined as 25-hydroxy Vit D<20 
ng/ml and 20≤VitD≤29, respectively. The epileptic 
medications were categorized as enzyme stimulants 
and non-stimulants, with the former including 
phenytoin, carbamazepine, phenobarbital, and 
primidone. The enzyme non-stimulants were 
lamotrigine, levetiracetam, topiramate, clobazam, 
sodium valproate, and ethosuximide. 
Statistics: The current study was approved by the 
ethics committee of the Shahid Beheshti University 
of Medical Sciences under the code “IR.SBMU.
MSP.REC.1396.668”. The central measures 
including means and standard deviations (SD) 
along with frequencies were reported using SPSS 
software. The confidence interval of 95%, the 
type-one error of 0.05, and the significance level 
of 0.05 were considered. An independent t-test and 
Chi-square tests were used for quantitative and 
qualitative variables, respectively. 
Ethics: No subject was enrolled in the study without 
written consent by the parents, and no extra charge 
or test was forced. All the laboratory data were 
safely kept by the principal investigators, and the 
families were informed by the feedback. 
Results
A total number of 120 individuals participated 
in the current study, including 60 cases and 60 
controls. Males made up 46.7% of the cases 
and 51.7% of the controls with no significant 
differences (P-value=0.715). Age was not different 
between the groups with the similar mean and SD 
of 5.72±2.9 years in the cases and 5.64±2.9 years 
in the controls. There was neither different height 
nor different weight comparing the groups. 
In terms of convulsion types, 60% of all the 
cases were generalized tonic-clonic followed 
by partial (23.3%), clonic (10%), absence (5%), 
and tonic (1.7%). Table 1 shows drugs used by 
the participants, of which 35% were stimulant 
drugs including phenytoin, carbamazepine, 
phenobarbital, and primidone and 65% were 
non-stimulants drugs such as sodium valproate, 
levetiracetam, topiramate, and ethosuximide. The 
mean duration of drug use was 8.6 months in the 
case group; while the control group took no drugs 
or placebos.
The average levels of Ca, P, and Vit D are reported 
in Table 2 in the both groups with similar values 
in Ca and P but a different value in Vit D (P 
value<0.001). There were three serum level 
ranges for each parameter to measure in this study. 
The elements Ca and P showed no difference 
between the groups at low, normal and high levels. 
However, Vit D significantly differed in the studied 
groups at the three levels (P-value=0.015) and Vit 
D insufficiency was obviously observed more in 
the cases. Similar findings were also obtained 
regarding the mean of the studied parameters, with 
Vit D as the only significantly different item after 
comparing the stimulant and non-stimulant drug 
users among the cases (P-value=0.04). Ca and P 
had very close levels between the cases using 
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the both groups of drugs (Table 1). Low, normal, 
and high levels of the elements and Vit D were 
compared between the stimulant and non-stimulant 
drug users to detect statistically similar results for 
all the three levels, as shown in Table 1. Table 3 
summarizes different ranges of Ca, P, and Vit D 
in the case group in terms of duration of drug use 
to present similar frequencies. With no statistically 
meaningful changes, Table 4 shows the gender 
mean of the participants.
Table 1. The use rates of the prescribed medications based on their metabolic mechanism in the case group and their effects on the 
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Table 2. Means and level classification of calcium, phosphorus, and vitamin D in the both groups




<8.5 n (%) 6(10) 2(3.3)
8.5-10.5 n (%) 40(66.7) 44(73.3)




<3.5 n (%) 3(5) 4(6.7)
3.5-5.5 n (%) 38(63.3) 30(50)




<20 n (%) 6(10) 4(6.7)
20-30 n (%) 23(38.3) 10(16.7)
>30 n (%) 31(51.7) 46(76.7)
Table 3. Means and level classification of calcium, phosphorus, and vitamin D in the case group based on the duration of antiepileptic 
treatment
Element Category Mean±SD min max Sig
Ca
Low 7.17±1.17 6 9
0.133
Normal 8.48±2.52 6 18
High 9.64±3.15 6 17
Total 8.62±2.64 6 18
P
Low 8±1 7 9
0.158
Normal 8.18±2.37 6 17
High 9.58±3.13 6 18
Total 8.62±2.64 6 18
Vit D
Low 8.67±1.86 7 12
0.993
Inadequate 8.57±2.48 6 18
Normal 8.65±2.94 6 17
Total 8.62±2.64 6 18
24
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Table 4. Distribution of the serum level of calcium, phosphorus, and vitamin D in the both groups based on the participants’ sex














The current study showed lower serum Vit D in the 
antiepileptic drug users, especially among children 
who took stimulant antiepileptics, although the 
serum level of Ca and P was not statistically 
different. The rates of Vit D deficiency and 
insufficiency were 10% and 38.3%, which were 
slightly lower than what Fong et al. (2014) reported 
(12). Borusiak et al. (2013) showed 13.3% Vit D 
reduction due to antiepileptics among 128 children 
who were healthy regardless of their epilepsy (9). 
This rate of reduction is less than what we claimed; 
however, hypocalcemia and hypophosphatemia 
were detected to be 24.4% and 25.4% in their study 
but only 10% and 5% in our study, respectively. 
Durá-Travé et al. considered valproic acid and 
levetiracetam as the main medications to treat Vit 
D deficiency through mono-therapy and reduce Ca 
(14). High alkaline phosphatase and low Ca serum 
levels were shown in a study on Indian epileptic 
children by Chaudhuri et al. who associated Vit 
D deficiency to carbamazepine mono-therapy 
followed by sodium valproate (15). They obtained 
an odds ratio of 4.0 in this regard, showing a 4-fold 
Vit D deficiency risk by valproic acid in children. 
Albaghdadi et al. concluded that the above 
mentioned medication caused low bone mineral 
density and hypovitaminosis D resulting from 
valproic acid in adults known as epileptic cases. This 
could raise the significance of monitoring epileptic 
patients for bone structure and osteoporosis during 
their childhood (16). On the contrary, Serin et al. 
and Paticheep et al. reported no bone mineral loss 
and Vit D deficiency in pediatric patients taking 
long-term antiepileptic drugs (17, 18). They also 
showed no difference between levetiracetam, as 
a bone-protective antiepileptic drug, and other 
medications usually prescribed for this purpose. 
Toopchizadeh et al. claimed that although Vit D 
deficiency and bone mineral density reduction 
were more prevalent in CP children compared with 
healthy ones, antiepileptic medications may need 
to be further investigated before being recognized 
as the main cause of these problems (19). 
Many studies investigating the effects of 
antiepileptic drugs on minerals and electrolytes in 
the body believed that the most frequent effects of 
these medications were on Ca, P, and Vit D. Among 
these studies is the one by Ashrafi who compared 
119 patients under antiepileptics with 119 
controls to show the effects of the aforementioned 
medications on bone minerals, especially PTH 
(20). Increased inactive forms of Vit D are mainly 
due to hepatic microsomal enzyme cytochrome 
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P450, which is chiefly directed by carbamazepine, 
phenytoin, phenobarbital, and primidone. On the 
other hand, phenytoin and phenobarbital could 
reduce Ca intestinal absorption. Moreover, these 
medications as well as carbamazepine and sodium 
valproate increase the bone metabolism rate, and 
the last two also inhibit the effect of parathormone 
on bone metabolism. Moreover, phenytoin inhibits 
activation of osteocalcin. It is not deniable that 
renal tubular metabolic disorders are among other 
causes of rickets through the increased urinary loss 
of Ca and P (21-24). We attempted to exclude all 
conditions affecting the serum level of Ca, P, Vit D 
to limit their alterations only to antiepileptics. 
In Conclusion
Antiepileptics were associated with the low serum 
level of Vit D in the treated children, especially those 
receiving stimulants, although these medications 
did not statistically affect the serum level of Ca 
and P in the current study. However, the authors 
recommend to conduct more multidisciplinary 
studies with bigger sample sizes, and also, to 
provide or revise clinical guidelines to select the 
best epilepsy treatment in children, especially in 
those at the risk of losing Ca, P, and Vit D due to 
any other condition. 
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